The state attorney general's office announced Wednesday that Kentucky is one of a number of states that is part of a $75.4 million federal and state settlement with a pharmaceutical subsidiary of Johnson & Johnson.
Ortho-McNeil-Janssen Pharmaceuticals was accused of illegally and improperly marketing the anti-seizure medication Topamax for uses not approved by the U.S. Food and Drug Administration.
Kentucky's state and federal portion of the settlement is $1.97 million, double the amount that Kentucky Medicaid spent on prescriptions written based on the marketing practices, according to a statement.
Sign Up and Save
Get six months of free digital access to the Lexington Herald-Leader